| ORDAVVEQ PFIZER INC.
2107186 14 May 2021 | on 26 Jul 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders; pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brain diseases and disorders, namely muscular dystrophy; Pharmaceutical preparations for the treatment of bone growth disorders; Pharmaceutical preparations for the treatment of the central nervous system, namely brain diseases and central nervous system movement disorders; Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, blood, and diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases and disorders, namely rheumatoid arthritis, systemic lupus, alopecia areata, and systemic sclerosis; Pharmaceutical preparations for the treatment of hypertension, menopause symptoms, obesity, stroke, arthritis, and pain; Pharmaceutical preparations for the treatment of cancer; Anti-infectives, anti-inflammatories, anti-viral agents, human vaccines; Pharmaceutical preparations for use in discouraging smoking habits; Pharmaceutical preparations for the treatment of kidney and liver disease and disorders; Pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely cachexia, diabetes, hypoglycemia, muscular dystrophy, obesity, sickle cell disease, non-alcoholic steatohepatitis (NASH) and anemia; Pharmaceutical preparations for the treatment of skin and dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, and viral skin infections. Pharmaceutical preparations for the treatment of muscular dystrophy. | | | OR-EQ ONKYO CORPORATION
1200569 29 Dec 2003 | on 07 Jul 2022 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Personal stereos; stereo amplifiers; stereo receivers; stereo tuners; audio/video receivers; television receivers; audio speakers; loudspeakers; cabinets for loudspeakers; headphones; horns for loudspeakers; speaker systems; remote controllers and remote control apparatus. | |